Literature DB >> 14575864

IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase.

Ron Kooijman1, Astrid Coppens, Elisabeth Hooghe-Peters.   

Abstract

Interleukin (IL)-8 serves as a major chemoattractant for neutrophils and has also been proposed to affect cancer progression. In the present study, we show that IGF-I stimulates IL-8 mRNA expression and IL-8 secretion in the leukemic cell line HL-60. Stimulation of IL-8 expression was completely attenuated by two inhibitors of mitogen-activated protein kinase (MAPK) kinase (MEK), which phosphorylates the MAPKs extracellular-regulated kinase (ERK)1 and ERK2, and by the c-Jun NH2-terminal kinase (JNK) inhibitor SP600125. In contrast, inhibitors of p38 MAPK and phosphatidylinositol-3 kinase (PI3K) did not abrogate the effect of IGF-I. We also show that IGF-I stimulates the activation of ERK1 and ERK2, but we could not detect any effect of IGF-I on the phosphorylation of p38, JNK(p46) or JNK(p54). Collectively, our results suggest that basal JNK activity and activation of the MEK-ERK pathway are required for upregulation of IL-8 by IGF-I in HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575864     DOI: 10.1016/s0898-6568(03)00069-x

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  12 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 2.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

3.  Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells.

Authors:  Allison N McCoy; Denise S Kim; Erin F Gillespie; Stephen J Atkins; Terry J Smith; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2014-03-26       Impact factor: 5.958

4.  IGF-1 can either protect against or increase LPS-induced damage in the developing rat brain.

Authors:  Yi Pang; Baoying Zheng; Leigh R Campbell; Lir-Wan Fan; Zhengwei Cai; Philip G Rhodes
Journal:  Pediatr Res       Date:  2010-06       Impact factor: 3.756

Review 5.  Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

Authors:  Terry J Smith; Laszlo Hegedüs; Raymond S Douglas
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

6.  Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone.

Authors:  Hena Alam; Jennifer Weck; Evelyn Maizels; Youngkyu Park; Eun Jig Lee; Margaret Ashcroft; Mary Hunzicker-Dunn
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

7.  Quadrupling efficiency in production of genetically modified pigs through improved oocyte maturation.

Authors:  Ye Yuan; Lee D Spate; Bethany K Redel; Yuchen Tian; Jie Zhou; Randall S Prather; R Michael Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

8.  miR-96, miR-145 and miR-9 expression increases, and IGF-1R and FOXO1 expression decreases in peripheral blood mononuclear cells of aging humans.

Authors:  Monika Budzinska; Magdalena Owczarz; Eliza Pawlik-Pachucka; Malgorzata Roszkowska-Gancarz; Przemyslaw Slusarczyk; Monika Puzianowska-Kuznicka
Journal:  BMC Geriatr       Date:  2016-11-30       Impact factor: 3.921

9.  Insulin-Like Growth Factor-1 Increases the Expression of Inflammatory Biomarkers and Sebum Production in Cultured Sebocytes.

Authors:  Hyojin Kim; Sun Young Moon; Mi Yeung Sohn; Weon Ju Lee
Journal:  Ann Dermatol       Date:  2017-02-03       Impact factor: 1.444

10.  Teprotumumab for thyroid eye disease: early response is not required for benefit.

Authors:  Shoaib Ugradar; Yao Wang; Tunde Mester; George J Kahaly; Raymond S Douglas
Journal:  Eye (Lond)       Date:  2021-06-28       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.